Cipla

GoApptiv is a company that provides comprehensive go-to-market solutions for pharmaceutical firms in India, focusing on enhancing healthcare access in extra-urban and rural areas. The company's offerings include a suite of healthcare software, featuring a digital payment and promotional platform, a doctor-patient engagement platform, and advanced data analytics tools. By leveraging these technologies and a network of distribution partners, GoApptiv aims to facilitate efficient market access, optimize patient experiences, and support organizational growth within the healthcare ecosystem. The integration of proprietary data analytics with innovative solutions positions GoApptiv as a key player in the evolving HealthTech landscape in India.

Ethris GmbH is a biotechnology company based in Planegg, Germany, specializing in the development of innovative therapeutic solutions for diseases with unmet medical needs. The company has a focus on transcript therapeutics, particularly through its SNIM RNA platform, which offers a novel approach to treating various conditions by enabling the production of therapeutic proteins within the patient’s body. This platform presents an alternative to traditional recombinant protein and gene therapies, addressing a range of diseases, including rare and genetically predetermined conditions. Ethris also develops Magnetovax, a personalized tumor vaccine platform that utilizes magnetic fields for localized activation in tumors. The company has established strategic research collaborations with major pharmaceutical firms, enhancing its capabilities in regenerative medicine and therapeutic development. Founded in 2009, Ethris continues to advance its technologies to meet diverse medical needs.

GoApptiv is a company that provides comprehensive go-to-market solutions for pharmaceutical firms in India, focusing on enhancing healthcare access in extra-urban and rural areas. The company's offerings include a suite of healthcare software, featuring a digital payment and promotional platform, a doctor-patient engagement platform, and advanced data analytics tools. By leveraging these technologies and a network of distribution partners, GoApptiv aims to facilitate efficient market access, optimize patient experiences, and support organizational growth within the healthcare ecosystem. The integration of proprietary data analytics with innovative solutions positions GoApptiv as a key player in the evolving HealthTech landscape in India.

GoApptiv is a company that provides comprehensive go-to-market solutions for pharmaceutical firms in India, focusing on enhancing healthcare access in extra-urban and rural areas. The company's offerings include a suite of healthcare software, featuring a digital payment and promotional platform, a doctor-patient engagement platform, and advanced data analytics tools. By leveraging these technologies and a network of distribution partners, GoApptiv aims to facilitate efficient market access, optimize patient experiences, and support organizational growth within the healthcare ecosystem. The integration of proprietary data analytics with innovative solutions positions GoApptiv as a key player in the evolving HealthTech landscape in India.

GoApptiv is a company that provides comprehensive go-to-market solutions for pharmaceutical firms in India, focusing on enhancing healthcare access in extra-urban and rural areas. The company's offerings include a suite of healthcare software, featuring a digital payment and promotional platform, a doctor-patient engagement platform, and advanced data analytics tools. By leveraging these technologies and a network of distribution partners, GoApptiv aims to facilitate efficient market access, optimize patient experiences, and support organizational growth within the healthcare ecosystem. The integration of proprietary data analytics with innovative solutions positions GoApptiv as a key player in the evolving HealthTech landscape in India.

Wellthy Therapeutics, established in 2015 and based in Mumbai, India, specializes in digital health solutions. It develops an AI-driven mobile application tailored for type-2 diabetes patients, offering real-time health coaching, personalized education, AI-powered query resolution, and a virtual clinical assistant for doctors. The app also includes features like a lifestyle tracker, interactive lessons, expert coaching, and detailed reports. Wellthy's mission is to bridge global health disparities by delivering scalable, clinically validated digital care solutions that improve patient outcomes and are compliant with regulations.

Cipla Medpro South Africa, a fully-owned subsidiary of Cipla India, is a prominent pharmaceutical company based in Bellville, recognized for producing high-quality medicines at affordable prices. It ranks among the largest pharmaceutical firms in South Africa by volume and is the third largest by value. With a portfolio exceeding 1,000 products across various therapeutic categories, Cipla Medpro employs advanced technology and innovation to address the healthcare needs of patients. The company is committed to agile and sustainable growth, focusing on complex generics and expanding its offerings in digital health and healthcare therapies. Cipla Medpro's dedication to quality and accessibility reflects its legacy as part of a respected global pharmaceutical brand operating in over 100 countries for nearly 80 years.

GoApptiv is a company that provides comprehensive go-to-market solutions for pharmaceutical firms in India, focusing on enhancing healthcare access in extra-urban and rural areas. The company's offerings include a suite of healthcare software, featuring a digital payment and promotional platform, a doctor-patient engagement platform, and advanced data analytics tools. By leveraging these technologies and a network of distribution partners, GoApptiv aims to facilitate efficient market access, optimize patient experiences, and support organizational growth within the healthcare ecosystem. The integration of proprietary data analytics with innovative solutions positions GoApptiv as a key player in the evolving HealthTech landscape in India.

InvaGen Pharmaceuticals, Inc. is a rapidly growing generic pharmaceutical company based in Hauppauge, New York. The company specializes in the development, manufacturing, marketing, and distribution of high-quality and cost-effective generic prescription medications. InvaGen focuses on a diverse range of therapeutic areas, including cardiovascular, anti-infective, central nervous system disorders, anti-inflammatory, anti-diabetic, and anti-depressant treatments. It offers various dosage forms, including immediate-release and modified-release capsules and tablets, to meet the needs of patients. With operations across multiple facilities in Hauppauge, InvaGen is committed to providing affordable healthcare solutions.

Exelan Pharmaceuticals is a privately held company specializing in the sales and marketing of generic pharmaceuticals aimed at the government and institutional markets. The company collaborates with a leading low-cost provider of pharmaceutical active pharmaceutical ingredients (APIs) and intermediates. Exelan Pharmaceuticals is committed to offering a diverse array of therapeutic products, ensuring accessibility and affordability in the pharmaceutical sector.

Quality Chemicals Limited imports and distributes human health, animal health, and environmental and public health products in Uganda.

Chase Pharmaceuticals Corporation is a specialty pharmaceutical company established in 2007 and headquartered in Washington, D.C. The company is dedicated to developing innovative medications aimed at treating Alzheimer's disease and related neurodegenerative disorders. Its primary product, CPC-252, is a transdermal formulation designed for managing the symptoms of Alzheimer's and Parkinsonism dementia. Chase Pharmaceuticals focuses on identifying and advancing promising treatments for central nervous system diseases, with a goal of addressing the significant unmet medical need in neuropsychiatry, particularly with Alzheimer’s disease, which is recognized as a major public health challenge. The company operates by selecting and developing product candidates that can be licensed to commercial partners, thus contributing to its strategic aim of improving the quality of life for those affected by cognitive decline. With an increasing global population affected by Alzheimer's and escalating healthcare costs, Chase Pharmaceuticals is positioned to play a crucial role in the development of more effective therapies for this condition.

Cipla Medpro South Africa, a fully-owned subsidiary of Cipla India, is a prominent pharmaceutical company based in Bellville, recognized for producing high-quality medicines at affordable prices. It ranks among the largest pharmaceutical firms in South Africa by volume and is the third largest by value. With a portfolio exceeding 1,000 products across various therapeutic categories, Cipla Medpro employs advanced technology and innovation to address the healthcare needs of patients. The company is committed to agile and sustainable growth, focusing on complex generics and expanding its offerings in digital health and healthcare therapies. Cipla Medpro's dedication to quality and accessibility reflects its legacy as part of a respected global pharmaceutical brand operating in over 100 countries for nearly 80 years.

Meditab Specialities Pvt. Ltd. engages in manufacturing and packing of pharmaceutical products such as tablets.